Advisory Commission on Childhood Vaccines; Notice of Meeting, 25836-25837 [05-9674]
Download as PDF
<![CDATA[
25836
Federal Register / Vol. 70, No. 93 / Monday, May 16, 2005 / Notices
Proposed Project: Ryan White
Comprehensive AIDS Resources
Emergency (CARE) Act Title I Grant
Application Information Supplements:
NEW
The CARE Act (codified under Title
XXVI of the Public Health Service Act)
was first enacted by Congress in 1990,
and reauthorized in 1996 and 2000. It
addresses the unmet health needs of
persons living with HIV disease by
funding primary health care and
support services that enhance access to
and retention in care. The CARE Act
funded services reach over 571,000
individuals; after Medicaid and
Medicare, it is the largest single source
of Federal funding for HIV/AIDS care
for low-income, uninsured, and
underinsured Americans. Title I under
the CARE Act provides emergency
assistance to eligible metropolitan areas
(EMAs) that have been most severely
affected by the HIV epidemic, for the
purpose of developing or enhancing a
continuum of high quality, communitybased care for low-income individuals
and families. HRSA disburses
approximately one-half of the Title I
funds among 51 EMAs based on a
congressionally-mandated formula. The
remaining funds are available on a
competitive basis to those same EMAs
that demonstrate severe need for
supplemental assistance to combat the
HIV epidemic, and an ability to disburse
and use supplemental resources in a
manner that is immediately responsive
to the local epidemic and cost effective.
The CARE Act requires local planning
councils to establish Title I priorities
and allocate funds, taking into account
critical factors. These include the: size
and demographics of the local HIV
epidemic; demonstrated (or probable)
cost effectiveness and outcome
effectiveness of proposed strategies and
interventions; priorities of the
communities with HIV disease for
whom the services are intended;
coordination of HIV care services
delivery with HIV prevention programs
and programs for the prevention and
treatment of substance abuse;
availability of other governmental and
nongovernmental resources; and
capacity development needs resulting
from disparities in the availability of
treatment and services in underserved
communities. Other planning council
duties include developing a
comprehensive plan for the delivery of
services and evaluating the effectiveness
of administrative mechanisms used by
the grantee to disburse (contract) the
funds locally.
The Title I Grant Application
Information Supplements have been
designed to collect information from
EMAs in a consistent, standard way
when they apply for new or competing
continuation grant funds in a combined
formula and supplemental grant
application. This information is needed
to determine that funds are being used
as intended by the Congress and in
compliance with CARE Act mandates,
and that supplemental funds are
awarded to grantees on the basis of
objective criteria consistent with CARE
Act requirements. This includes
requirements that grantees demonstrate:
(a) Severity of need for emergency
assistance to combat the HIV epidemic,
including the unmet needs of persons
who know their HIV status but are not
yet in care, (Information Supplements 1,
4 and 5); (b) a functioning planning
council that is in conformance with
statutory membership requirements and
carrying out mandated duties and
responsibilities, (Information
Supplement 2); (c) an ability to use Title
I grant resources in a manner that is
immediately responsive to the local
epidemic and cost effective, and in
compliance with payer of last resort,
maintenance of effort and related
requirements, (Information
Supplements 3 and 6); and (d) a
comprehensive plan for the delivery of
HIV/AIDS care services that is
responsive to the local epidemic and
unmet needs, (Information Supplements
7 and 8).
In addition, HRSA will use the
collected information as a benchmark
for monitoring grantee performance
during the fiscal year; to identify
individual and cross-cutting grantee
technical assistance needs; and to detect
emerging HIV/AIDS care services issues
that may require changes in existing
program policies or procedures.
The Title I Application Information
Supplements will be transmitted by
mail and electronically to all Title I
EMAs and made available through the
HRSA Web site. Applicants will submit
the Information Supplements
electronically along with Form PHS–
5161–1 (Revised 7/00), SF–424 and the
program narrative portion of their
application, using the Grants
Management electronic transmission
mechanisms established by HRSA. The
Information Supplements will include
check box responses; fields for reporting
numeric fiscal and epidemiological
data; and text boxes for describing other
required information. The Information
Supplements will automatically
generate totals when appropriate, and
have other automated fields to minimize
the time required to insert identifying
information.
The Information Supplements will
require Title I applicants/grantees to
report local epidemiological information
and some fiscal and programmatic data
collected from Title I funded contractors
(sub-grantees), which grantees have
been collecting and reporting since FY
1995 or earlier. The approximate
response burden for applicants/grantees
is estimated as:
Estimated number of
grantee respondents
Estimated
responses per
grantee
Total number
of responses
Hours per
response
Estimated total
hour burden
51 .....................................................................................................................
1
51
16
816
Send comments to Susan G. Queen,
PhD, HRSA Reports Clearance Officer,
Room 10–33, Parklawn Building, 5600
Fishers Lane, Rockville, MD 20857.
Written comments should be received
within 60 day of this notice.
Dated: May 10, 2005.
Tina M. Cheatham,
Director, Division of Policy Review and
Coordination.
[FR Doc. 05–9677 Filed 5–13–05; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4165–15–P
Advisory Commission on Childhood
Vaccines; Notice of Meeting
Health Resources and Services
Administration
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
VerDate jul<14>2003
16:37 May 13, 2005
Jkt 205001
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
E:\FR\FM\16MYN1.SGM
16MYN1
Federal Register / Vol. 70, No. 93 / Monday, May 16, 2005 / Notices
(Pub. L. 92–463), notice is hereby given
of the following meeting:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Name: Advisory Commission on
Childhood Vaccines (ACCV).
Dates and Times: The full ACCV will meet
on June 1, 2005, 1 p.m.–5:30 p.m., e.d.t., and
June 2, 2005, 9 a.m.–2 p.m., e.d.t.
Place: Audio Conference Call and
Parklawn Building, Conference Rooms G & H,
5600 Fishers Lane, Rockville, MD 20857.
Status: The meeting will be open to the
public. The public can join the meeting in
person at the address listed above or by audio
conference call by dialing 1–888–323–5255
on June 1–2 and providing the following
information:
Leader’s Name: Dr. Geoffrey Evans.
Password: ACCV.
Agenda: The agenda items for the June
meeting will include, but are not limited to:
A report from the ACCV Workgroup meeting;
a presentation and discussion on the draft
vaccine information statements for
diphtheria-tetanus-pertussis, haemophilus
influenzae, polio, pneumococcal conjugate,
hepatitis B, and influenza vaccines; a
discussion on adding injuries for influenza
vaccine to the Vaccine Injury Table; and
updates from the Division of Vaccine Injury
Compensation (DVIC), the Department of
Justice, and the National Vaccine Program
Office. Agenda items are subject to change as
priorities dictate.
Public Comments: Persons interested in
providing an oral presentation should submit
a written request, along with a copy of their
presentation to: Ms. Cheryl Lee, Principal
Staff Liaison, DVIC, Healthcare Systems
Bureau (HSB), Health Resources and Services
Administration (HRSA), Room 11C–26, 5600
Fishers Lane, Rockville, Maryland 20857 or
e-mail clee@hrsa.gov. Requests should
contain the name, address, telephone
number, and any business or professional
affiliation of the person desiring to make an
oral presentation. Groups having similar
interests are requested to combine their
comments and present them through a single
representative. The allocation of time may be
adjusted to accommodate the level of
expressed interest. DVIC will notify each
presenter by mail or telephone of their
assigned presentation time.
Persons who do not file an advance request
for a presentation, but desire to make an oral
statement, may announce it at the time of the
comment period. These persons will be
allocated time as it permits.
For Further Information Contact: Anyone
requiring information regarding the ACCV,
should contact Ms. Cheryl Lee, Principal
Staff Liaison, DVIC, HSB, HRSA, Room 11C–
26, 5600 Fishers Lane, Rockville, MD 20857;
telephone (301) 443–2124 or e-mail
clee@hrsa.gov.
Substance Abuse and Mental Health
Services Administration
Dated: May 10, 2005.
Tina M. Cheatham,
Director, Division of Policy Review and
Coordination.
[FR Doc. 05–9674 Filed 5–13–05; 8:45 am]
BILLING CODE 4165–15–U
VerDate jul<14>2003
16:37 May 13, 2005
Jkt 205001
Center for Substance Abuse
Prevention; Notice of Meeting
Pursuant to Pub. L. 92–463, notice is
hereby given of the meeting of the
SAMHSA Center for Substance Abuse
Prevention (CSAP) National Advisory
Council on May 25–26, 2005.
The meeting will be open and will
include a Director’s Report, and
discussion of the Center’s policy issues
and current administrative, legislative,
and program developments. The
meeting will also include a presentation
on the Center’s National Prevention
Partners initiative.
Substantive program information, a
summary of the meeting, and a roster of
Council members may be obtained
either by accessing the SAMHSA
Council Web site, https://
www.samhsa.gov/council/csap/
csapnac.aspx or by communicating with
the contact listed below. The transcript
for the open session will also be
available on the SAMHSA CSAP
Council Web site as soon as possible
after the meeting.
Committee Name: Substance Abuse and
Mental Health Services Administration,
Center for Substance Abuse Prevention
National Advisory Council.
Date/Time: Wednesday, May 25, 2005, 2
p.m. to 5 p.m., Thursday, May 26, 2005, 9
a.m. to 3 p.m.
Place: 1 Choke Cherry Road, Sugarloaf
Conference Room, Rockville, Maryland
20857.
Type: Open.
Contact: Tia Haynes, Committee
Management Specialist, 1 Choke Cherry
Road, 4–1054, Rockville, Maryland 20857,
Telephone: (240) 276–2436, Fax: (240) 276–
2439, E-mail: Tia.haynes@samhsa.hhs.gov.
Dated: May 10, 2005.
Toian Vaughn,
Committee Management Officer, Substance
Abuse and Mental Health Services
Administration.
[FR Doc. 05–9661 Filed 5–13–05; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Federal Emergency
Management Agency, Emergency
AGENCY:
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
25837
Preparedness and Response Directorate,
U.S. Department of Homeland Security.
ACTION: Notice and request for
comments.
SUMMARY: The Federal Emergency
Management Agency, as part of its
continuing effort to reduce paperwork
and respondent burden, invites the
general public and other Federal
agencies to take this opportunity to
comment on two proposed revisions to
information collection requests
currently approved under OMB control
numbers 1660–0071 and 1660–0072. In
accordance with the Paperwork
Reduction Act of 1995 (44 U.S.C.
3506(c)(2)(A)), this notice seeks
comments concerning these collections
that are used by: (1) Grantees to apply
for and report on eGrant awards; and,
(2) FEMA to evaluate, award, and
monitor expenditures and program/
project performance for Pre-Disaster
Mitigation (PDM) and Flood Mitigation
Assistance (FMA) program activities.
SUPPLEMENTARY INFORMATION: The
proposed information collection
requests, upon approval by OMB, will
enable FEMA to continue using eGrant
applications and reporting for the PreDisaster Mitigation (PDM) program and
the Flood Mitigation Assistance (FMA)
program, which are essential to FEMA’s
mission to lead America to prepare for
prevent, respond to, and recover from
disasters. The PDM grant program is the
only source of Federal pre-disaster
funding available to States and local
governments for hazard mitigation.
Hazard mitigation is an ongoing effort to
lessen the impact disasters have on
people’s lives and property through
damage prevention measures such as
removing homes from the floodplain,
engineering buildings and infrastructure
to withstand earthquakes, installing safe
rooms and retrofitting buildings to
withstand high winds from tornadoes or
hurricanes.
The Disaster Mitigation Act of 2000
(Pub. L. 106–390) authorizes and funded
the Pre-Disaster Mitigation (PDM)
program to provide a continuous source
of pre-disaster mitigation funding
independent of disaster declarations to
assist States and local communities to
take actions to reduce the overall risks
to populations and to properties from
future disasters. The Flood Mitigation
Assistance (FMA) program is an annual
program targeted toward reducing flood
damages and risks to people and
properties. The National Flood
Insurance Act of 2004 (Pub. L. 108–264)
amended the FMA program by
expanding the authorized funds from
$20 million to $40 million annually to
E:\FR\FM\16MYN1.SGM
16MYN1
]]>Agencies
[Federal Register Volume 70, Number 93 (Monday, May 16, 2005)]
[Notices]
[Pages 25836-25837]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-9674]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Advisory Commission on Childhood Vaccines; Notice of Meeting
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act
[[Page 25837]]
(Pub. L. 92-463), notice is hereby given of the following meeting:
Name: Advisory Commission on Childhood Vaccines (ACCV).
Dates and Times: The full ACCV will meet on June 1, 2005, 1
p.m.-5:30 p.m., e.d.t., and June 2, 2005, 9 a.m.-2 p.m., e.d.t.
Place: Audio Conference Call and Parklawn Building, Conference
Rooms G & H, 5600 Fishers Lane, Rockville, MD 20857.
Status: The meeting will be open to the public. The public can
join the meeting in person at the address listed above or by audio
conference call by dialing 1-888-323-5255 on June 1-2 and providing
the following information:
Leader's Name: Dr. Geoffrey Evans.
Password: ACCV.
Agenda: The agenda items for the June meeting will include, but
are not limited to: A report from the ACCV Workgroup meeting; a
presentation and discussion on the draft vaccine information
statements for diphtheria-tetanus-pertussis, haemophilus influenzae,
polio, pneumococcal conjugate, hepatitis B, and influenza vaccines;
a discussion on adding injuries for influenza vaccine to the Vaccine
Injury Table; and updates from the Division of Vaccine Injury
Compensation (DVIC), the Department of Justice, and the National
Vaccine Program Office. Agenda items are subject to change as
priorities dictate.
Public Comments: Persons interested in providing an oral
presentation should submit a written request, along with a copy of
their presentation to: Ms. Cheryl Lee, Principal Staff Liaison,
DVIC, Healthcare Systems Bureau (HSB), Health Resources and Services
Administration (HRSA), Room 11C-26, 5600 Fishers Lane, Rockville,
Maryland 20857 or e-mail clee@hrsa.gov. Requests should contain the
name, address, telephone number, and any business or professional
affiliation of the person desiring to make an oral presentation.
Groups having similar interests are requested to combine their
comments and present them through a single representative. The
allocation of time may be adjusted to accommodate the level of
expressed interest. DVIC will notify each presenter by mail or
telephone of their assigned presentation time.
Persons who do not file an advance request for a presentation,
but desire to make an oral statement, may announce it at the time of
the comment period. These persons will be allocated time as it
permits.
For Further Information Contact: Anyone requiring information
regarding the ACCV, should contact Ms. Cheryl Lee, Principal Staff
Liaison, DVIC, HSB, HRSA, Room 11C-26, 5600 Fishers Lane, Rockville,
MD 20857; telephone (301) 443-2124 or e-mail clee@hrsa.gov.
Dated: May 10, 2005.
Tina M. Cheatham,
Director, Division of Policy Review and Coordination.
[FR Doc. 05-9674 Filed 5-13-05; 8:45 am]
BILLING CODE 4165-15-U
